Who gets NTM disease?
Some people are at higher risk of getting an NTM infection and developing disease. People who have an existing lung disease such as bronchiectasis (enlargement of airways), chronic obstructive pulmonary disease (COPD), cystic fibrosis, alpha-1 antitrypsin deficiency or who have had prior infections such as tuberculosis are at increased risk of pulmonary NTM disease. Patients with advanced HIV infection (CD4 <50) or immune-related genetic disorders such as (interferon-gamma deficiency or receptor deficiency, interleukin-12 deficiency) may develop pulmonary disease as part of a disseminated NTM (widespread in the body) infection.
What are the signs and symptoms of NTM pulmonary disease? NTM causes symptoms similar to a chronic and non-resolving pneumonia. Common symptoms include: 
How is NTM disease diagnosed?
It is difficult to distinguish who is simply carrying NTM bacteria and is not ill from it, (which we called colonized) from those with true NTM disease. Cultures to try to grow the bacteria are also done. Some NTM grow rapidly in culture-within a few days-but some types take several weeks to be detected in the culture. Collection of three early-morning sputum samples on different days is preferred for diagnosis of NTM lung disease. Bronchoscopy is sometimes needed to obtain lung samples. (See ATS Patient Information Series 'Flexible Bronchoscopy' at www.thoracic.org/ patients) If other parts of the body are affected, fluid sampling or tissue biopsy may be needed. Your health care provider will order other tests including chest imaging such as a plain X-ray and a CT scan. Your health care provider will discuss which tests are best for you and what the results show. Repeat sputum cultures are typically done during treatment to measure its success.
What is Nontuberculous

How is NTM disease treated?
Treatment and outcomes depend on which NTM species is causing disease. A decision to treat NTM disease is often based on symptoms, microbiological culture data and other test results. Typically NTM pulmonary disease is treated with three or more antibiotics until sputum cultures have been negative for 12 months. Commonly used antibiotics include macrolides, ethambutol, rifamycins, aminoglycosides, fluoroquinolones, imipenem and linezolid. Treatment may be complicated by potential toxicity or side-effects with the use of these antibiotics. Treatment is usually done by a lung or infectious disease specialist who has experience treating NTM infection. Therefore, you will require close follow up during treatment. Other therapies may also be used, such as airway clearance.
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